Study calls for research on the efficacy and safety of vena cava filters
An evaluation of practice patterns in California hospitals showed a large variation in the use of metal devices called inferior vena cava filters, or VCFs, despite little evidence of their safety and effectiveness.
Led by UC Davis physicians, the study demonstrated that hospital rather than patient characteristics best predict VCF use. Patients in larger, urban and private hospitals with more than 400 beds were most likely to be treated with one of the metal devices, which are placed intravenously to prevent pulmonary embolism, a serious and often deadly condition that occurs when blood clots migrate from the legs to the lungs.
Published in JAMA Internal Medicine, a JAMA Network publication, the finding leads the authors to recommend additional research of VCF use to determine if the devices improve outcomes for patients who develop blood clots in large, deep veins—a condition known as venous thromboembolism.
"There is little medical evidence that this device does what it is assumed to do, which is prevent pulmonary embolism and save lives," said lead author Richard White, chief of general medicine and medical director of the anticoagulation service at UC Davis. "The decision seems to be driven instead by hospital culture, likely reflecting the opinions of key physicians."
The recommended treatment for venous thromboembolism is anticoagulant medication that thins the blood, stopping clots from forming and reducing the likelihood that clot parts will break off and travel. This option, however, may not be available for patients who are actively bleeding, are very ill or need urgent surgery.
First developed in the 1980s, the VCF is a device with metal struts that is inserted into the largest vein that runs from the legs to the heart. The belief is that the device blocks the passage of large clots, or at least breaks them up into small pieces that may not cause as much damage. Use of the device is growing, with a more than three-fold increase between 1996 and 2009 in California.
"If we cannot administer a blood-thinning anticoagulant, it may seem logical to use one of these filter devices," said White. "The problem is that there isn't any solid proof that this option actually benefits patients. There is also distressing evidence that the majority of the devices are left inside patients and never removed. Over months and years, the device can break apart and become harmful."
For their retrospective, observational study, White and his colleagues reviewed data from the California Patient Discharge database, which includes patient diagnoses, procedures, demographics and related hospitalization information. All hospitals that admitted more than 55 non-trauma patients diagnosed with a blood clot in one of their legs or pulmonary embolism between January 2006 and December 2010 were included. The final evaluation involved a total of 263 California hospitals and 130,643 patients. Among these patients, 19,537 received a VCF.
The team found an extraordinarily wide variability—from 0 percent to close to 40 percent—in the percentages of patients with blood clots who received VCFs. This large variation was even apparent in neighboring hospitals in the same communities and within large hospital systems. Small hospitals of less than 100 beds and hospitals located in rural areas were the least likely to use the device. Characteristics such as socioeconomic factors and insurance coverage did not seem to play major roles in the decision to insert the device.
"We assume that some of this variation is related to the wider availability of specialists at larger, urban hospitals who can insert endovascular devices," said White. "The enthusiasm of individual physician leaders within each hospital could also play a central role in explaining the variation across hospitals."
A few patient conditions—particularly metastatic cancer, bleeding or planned surgery—were associated with more frequent use of VCFs, but these conditions were present in only a small percentage of the patients included in the study data.
"These are all very good reasons for considering alternatives to anticoagulant medications, but there is still very little confirmation that the device works," said White.
Rather than leave the decision up to specialist availability or individual physicians, the research team recommended comparative effectiveness studies of using versus not using a VCF.
"The decision to use any medical device should be based on its known benefits in comparison to other options, which could include careful monitoring," said White. "We have set the stage for a study to compare how well the VCF works in saving patients' lives when anticoagulation therapy is not possible."
Journal reference: JAMA Internal Medicine
Provided by UC Davis
- Study tracks variation between hospitals in vena cava filter use Mar 18, 2013 | not rated yet | 0
- Fewer than 1 in 5 patients receive treatment to prevent life-threatening blood clots Jun 02, 2008 | not rated yet | 0
- ACP recommends new approach to prevent venous thromboembolism in hospitalized patients Oct 31, 2011 | not rated yet | 0
- What's causing life-threatening blood clots in brain surgery patients? Sep 03, 2010 | not rated yet | 0
- Aspirin may prevent recurrence of deep vein blood clots May 23, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Indeterminism in Classical Physics
2 hours ago I was reading the Roger Penrose book Emperor's New Mind and he was explaining the determinism in Newtonian mechanics. He says that if we consider...
Current in two wires
2 hours ago Wire A and B, which have the same cross-sectional area are connected in series. There is a p.d. V across the whole wire. Suppose the two wires...
understanding the dipole model for Rayleigh scattering
4 hours ago Hello. I am currently studying scattering theory in detail for my BSc thesis, and I'm starting with Rayleigh scattering. I'm following Scattering...
question on coriolis effect with drag force
10 hours ago I really need help with this question. A small floating object initially moves with velocity v on the surface of a liquid at latitude λ. The...
Question of reflection and transmission of TEM wave in normal incidenc
16 hours ago Suppose TEM wave in +z normal to a boundary on xy plane at z=0. We know *E* & *H* are tangential to the boundary. Let ##\vec E_i=\hat x E##, be the...
the rudyak-krasnolutski effective potencial
17 hours ago Hi ... anyone now how to calculate or the formula of the rudyak-krasnolutski EFFECTIVE potencial ? the effective potencial includes the angular...
- More from Physics Forums - Classical Physics
More news stories
Routinely measuring fractional flow reserve (FFR) using pressure wire assessment during coronary angiography for diagnosis of chest pain leads to significant changes in the management of one in four patients, according to ...
Cardiology 6 minutes ago | not rated yet | 0
A new investigational device - the Helio System (TF-FA) - being developed for use with the Sapien XT Transcatheter Heart Valve was successfully deployed in all four patients in a small, first-in-human feasibility study of ...
Cardiology 24 minutes ago | not rated yet | 0
Cardiac study used as source for new guidelines on treating people undergoing coronary artery bypass surgery
Cardiac research from the University of Alberta had serious impact as a source for the American College of Cardiology and the American Heart Association's new guidelines on how to treat patients undergoing coronary artery ...
Cardiology 56 minutes ago | not rated yet | 0
(HealthDay)—In patients who have previously been considered difficult to image, dual-source cardiac (DSC) computed tomography (CT) can identify clinically significant coronary artery disease, according ...
Cardiology 14 hours ago | not rated yet | 0
UCLA researchers examining outcomes for advanced heart-failure patients over the past two decades have found that, coinciding with the increased availability and use of new therapies, overall mortality has decreased and sudden ...
Cardiology 17 hours ago | not rated yet | 0
(Medical Xpress)—The way Alzheimer's disease is portrayed by advocacy groups and the media is having undue influence on the euthanasia debate, according to a Deakin University nursing ethics professor.
1 hour ago | not rated yet | 0
(Medical Xpress)—Patients with diabetes who are depressed are much more likely to develop episodes of dangerously low blood sugars, or hypoglycemia, than are those who are not depressed, a new study has ...
1 hour ago | not rated yet | 0 |
(Medical Xpress)—UCD researchers led by Conway Fellow, Professor David Brayden in UCD School of Veterinary Medicine have successfully reduced inflammation in the swollen arthritic knees of a murine model using a novel nanoparticle.
16 minutes ago | not rated yet | 0
(Medical Xpress)—Curtin University researchers have found evidence that targeting specific cells in the body can reverse the effects of cancer on the immune system.
36 minutes ago | 5 / 5 (1) | 0
Transformative research from Western University has identified new hormones in the body which may suppress breast cancer and stimulate the regression of breast tumors.
26 minutes ago | not rated yet | 0
A new program for treating the emotional health of mothers of children with ADHD has shown significant benefits for the children themselves, finds a new study by University of Maryland researchers. The program combines treatment ...
36 minutes ago | not rated yet | 0